What's breaking now, across thousands of outlets.
A new study published in Neurology reveals that stroke rates among young adults have nearly doubled over the past three decades, driven by rising risk factors.
We haven't written up this one. 3News has the full story — the link below goes straight to it.
FDA clearance expands development of forazapadin into a second degenerative muscle disease with significant unmet medical need FSHD Canada Foundation to provide up to US$5 million in non-dilutive…
The Cancer Aid & Research Foundation (CARF) organised a special “Rose Day of Joy” programme for children battling cancer, giving them a break from treatment through a day of entertainment and…
New research from the University of Colorado Anschutz Department of Medicine is shedding light on how women and men with chronic kidney disease (CKD) may fare differently as they age and their disease…
— Meaningful and consistent efficacy trends across endpoints support continuing with Phase 3 development of 60 mg once daily remlifanserin in ADP, with demonstrated evidence of dose effect — Narrowly…
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced encouraging findings from a…
